Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuromyelitis optica.

Bruce A C Cree1, Douglas S Goodin, Stephen L Hauser

  • 1Department of Neurology, University of California San Francisco, USA.

Seminars in Neurology
|January 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026
Same author

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

European journal of neurology·2026
Same author

Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior Immunosuppressants.

Annals of clinical and translational neurology·2026
Same author

Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Annals of neurology·2026
Same author

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants.

Annals of clinical and translational neurology·2026
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Neuromyelitis optica (NMO) involves optic neuritis and myelitis. Its association with various diseases suggests it may not be a unique entity but rather a phenotype occurring in different conditions.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Neuromyelitis optica (NMO) is characterized by optic neuritis and myelitis.
  • Its classification as a distinct disease versus a variant of multiple sclerosis (MS) remains debated.
  • The NMO phenotype is observed in various inflammatory and infectious disorders.

Purpose of the Study:

  • To systematically review the literature on NMO.
  • To clarify the nosology and associations of NMO with other diseases.
  • To review current understanding of NMO pathogenesis and treatment.

Main Methods:

  • Systematic literature review using MEDLINE.
  • Analysis of historical data, neuropathology, clinical course, and associations.
  • Synthesis of information on pathogenesis and therapeutic strategies.

Related Experiment Videos

Main Results:

  • NMO shares features with MS and other inflammatory conditions.
  • The occurrence of NMO symptoms across diverse diseases challenges its status as a singular entity.
  • Distinct neuropathological findings and aggressive clinical progression are noted in NMO.

Conclusions:

  • The NMO phenotype can manifest in various disease states, suggesting it may not be a specific clinical entity.
  • Further research is needed to fully elucidate the pathogenesis and optimal treatment of NMO.
  • Understanding NMO's associations is crucial for accurate diagnosis and management.